TY - JOUR
T1 - Increase in Mental Disorders During the COVID-19 Pandemic-The Role of Occupational and Financial Strains
AU - Dragano, Nico
AU - Reuter, Marvin
AU - Peters, Annette
AU - Engels, Miriam
AU - Schmidt, Börge
AU - Greiser, Karin H
AU - Bohn, Barbara
AU - Riedel-Heller, Steffi
AU - Karch, André
AU - Mikolajczyk, Rafael
AU - Krause, Gérard
AU - Lang, Olga
AU - Panreck, Leo
AU - Rietschel, Marcella
AU - Brenner, Hermann
AU - Fischer, Beate
AU - Franzke, Claus-Werner
AU - Gastell, Sylvia
AU - Holloczek, Bernd
AU - Jöckel, Karl-Heinz
AU - Kaaks, Rudolf
AU - Keil, Thomas
AU - Kluttig, Alexander
AU - Kuß, Oliver
AU - Legath, Nicole
AU - Leitzmann, Michael
AU - Lieb, Wolfgang
AU - Meinke-Franze, Claudia
AU - Michels, Karin B
AU - Obi, Nadia
AU - Pischon, Tobias
AU - Feinkohl, Insa
AU - Rospleszcz, Susanne
AU - Schikowski, Tamara
AU - Schulze, Matthias B
AU - Stang, Andreas
AU - Völzke, Henry
AU - Willich, Stefan N
AU - Wirkner, Kerstin
AU - Zeeb, Hajo
AU - Ahrens, Wolfgang
AU - Berger, Klaus
N1 - Funding
This project was conducted with data of the German National Cohort (NAKO) Study (www.nako.de). The German National Cohort (NAKO) Study has been funded by the German Federal Ministry of Education and Research (BMBF, Bundesministerium für Bildung und Forschung) (grant number 01ER1301A/B/C und 01ER1511D), the Federal States (“Länder”) and the Helmholtz Association, as well as the participating universities and institutes of the Leibniz Association. The analysis was developed within the context of the MethodCoV method platform, which has been funded by the Federal Ministry of Education and Research (BMBF) (grant number 01KX2021). We thank all participants and staff members of the German National Cohort (NAKO) Study.
PY - 2022
Y1 - 2022
N2 - BACKGROUND: Numerous studies have reported an increase in mental disorders during the COVID-19 pandemic, but the exact reasons for this development are not well understood. In this study we investigate whether pandemic-related occupational and financial changes (e.g., reduced working hours, working from home, financial losses) were associated with increased symptoms of depression and anxiety compared with the situation before the pandemic.METHODS: We analyzed data from the German National Cohort (NAKO) Study. Between May and November 2020, 161 849 study participants answered questions on their mental state and social circumstances. Their responses were compared with data from the baseline survey before the pandemic (2014-2019). Linear fixed-effects models were used to determine whether individual changes in the severity of symptoms of depression (PHQ-9) or anxiety (GAD-7) were associated with occupational/ financial changes (controlling for various covariates).RESULTS: The prevalence of moderate or severe symptoms of depression and anxiety increased by 2.4% and 1.5%, respectively, during the COVID-19 pandemic compared with the preceding years. The mean severity of the symptoms rose slightly. A pronounced increase in symptoms was observed among those who became unemployed during the pandemic (+ 1.16 points on the depression scale, 95% confidence interval [0.91; 1.41], range 0-27). Increases were also seen for reduced working hours with no short-time allowance, increased working hours, working from home, insecurity regarding employment, and financial strain. The deterioration in mental health was largely statistically explained by the occupational and financial changes investigated in the model.CONCLUSION: Depressive symptoms and anxiety disorders increased slightly in the study population during the first year of the COVID-19 pandemic. Occupational and financial difficulties were an essential contributory factor. These strains should be taken into account both in the care of individual patients and in the planning of targeted prevention measures.
AB - BACKGROUND: Numerous studies have reported an increase in mental disorders during the COVID-19 pandemic, but the exact reasons for this development are not well understood. In this study we investigate whether pandemic-related occupational and financial changes (e.g., reduced working hours, working from home, financial losses) were associated with increased symptoms of depression and anxiety compared with the situation before the pandemic.METHODS: We analyzed data from the German National Cohort (NAKO) Study. Between May and November 2020, 161 849 study participants answered questions on their mental state and social circumstances. Their responses were compared with data from the baseline survey before the pandemic (2014-2019). Linear fixed-effects models were used to determine whether individual changes in the severity of symptoms of depression (PHQ-9) or anxiety (GAD-7) were associated with occupational/ financial changes (controlling for various covariates).RESULTS: The prevalence of moderate or severe symptoms of depression and anxiety increased by 2.4% and 1.5%, respectively, during the COVID-19 pandemic compared with the preceding years. The mean severity of the symptoms rose slightly. A pronounced increase in symptoms was observed among those who became unemployed during the pandemic (+ 1.16 points on the depression scale, 95% confidence interval [0.91; 1.41], range 0-27). Increases were also seen for reduced working hours with no short-time allowance, increased working hours, working from home, insecurity regarding employment, and financial strain. The deterioration in mental health was largely statistically explained by the occupational and financial changes investigated in the model.CONCLUSION: Depressive symptoms and anxiety disorders increased slightly in the study population during the first year of the COVID-19 pandemic. Occupational and financial difficulties were an essential contributory factor. These strains should be taken into account both in the care of individual patients and in the planning of targeted prevention measures.
KW - Anxiety/epidemiology
KW - COVID-19/epidemiology
KW - Depression/diagnosis
KW - Humans
KW - Mental Disorders/epidemiology
KW - Pandemics
KW - SARS-CoV-2
U2 - 10.3238/arztebl.m2022.0133
DO - 10.3238/arztebl.m2022.0133
M3 - Article
C2 - 35197188
SN - 1866-0452
VL - 119
SP - 179
EP - 187
JO - Deutsches Arzteblatt International
JF - Deutsches Arzteblatt International
IS - 11
ER -